National and Kapodistrian University of Athens
Διαφορές μεταξύ καρκίνων δεξιού και αριστερού τμήματος του παχέος εντέρου σε στάδιο, διαφοροποίηση και ορισμένους ανοσοϊστοχημικούς δείκτες
Abstract
dc:descriptionIntroduction. Right and left-sided colorectal adenocarcinomas are considered following a different model of tumorigenesis leading to a different biologic behavior and clinical manifestation. Aim - Materials and Methods. In this study, 36 proximal colorectal adenocarcinomas were compared to 83 distal cancers, concerning tumor stage, grade Ki-67, p53, Bcl-2, EGFR and MVD (microvascular density) assessed with CD₃₄. Patients pathology reports were respectively studied and immunohistochemical staining was performed using Ki-67, p53, Bcl-2, EGFR and CD₃₄ antibodies. Results: There were no statistically significant differences, concerning tumor stage, Bcl-2, EGFR and CD₃₄ expression. However, specific differences were detected in certain sub-groups in females Bcl-2(+) tumors were more frequently observed distally (p=0,008) while in patients with stage A predominance of EGFR(+) stain was found proximally (p=0,018). As for the grade, lesions with poor differentiation were more frequently observed in the right colon (p=0,005), while those with intermediate differentiation were mainly detected at the left side (p=0,001). Tumors with Ki-67 (over the level of 20% stained nuclei) were mostly observed distally, while lesions with lower staining were mainly found proximally (p=0,026). Similar differences were specifically presented in tumors with advanced stage (p=0,046) and intermediate grade (p=0,043). p53 expression was different between the two comparing distributions (p=0,011) with a superiority of distal lesions noted over the level of 30% stained nuclei, and a concentration of proximal tumors below it (p=0,0014). Such differences were specifically depicted in stages Β, C and D (p=0,03, 0,04, 0,035, respectively), in advanced stage disease (p=0,007) and finally in lesions of intermediate grade (p=0,002). Besides segmental comparisons Bcl₂ expression was significantly associated with tumor stage (p=0,02) Bcl₂ (+) stains were detected more frequently in tumors with primary stage (p=0,049), specifically in stage Β (p=0,004). Of note, this association was documented only in distal but not in proximal tumors, when each segmental group was individually examined. As regards grade, Bcl₂ (+) expression was found significantly related to Grade II lesions, (p=0,004). Such associations were not side-specific (they were observed in both proximal and distal tumors). On the contrary Bcl-2(-) staining was found related to Grade III lesions (p=0,028). A trend of progressive changing in the percentage of EGFR(+) tumours, was observed within stage distribution (from A to D) , presenting in an inverse way in each side (decrease on the right, increase on the left). However, this trend was significant only for proximal tumours, with stage A (p=0,023). Moreover, p53 overexpression (≥ 65% stained nuclei) was found significantly related to stage D (p=0,03). The finding was observed only in distal tumours (p=0,008). Finally, increased MVD (assesed with CD₃₄) appeared to associate with advanced stage disease, but only for left - sided cancers (p=0,046). Conclusion: Remarkable differences concerning Grade of differentiation (worst for right lesions), Ki-67 and p53 expression (both higher in distal lesions) were observed between proximal and distal colorectal carcinomas.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2007
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Papagiorgis, Petros
- Παπαγιώργης, Πέτρος
Subjects
dc:subject × 16- Δεξιοί ορθοκολικοί όγκοι
- Αριστεροί ορθοκολικοί όγκοι
- Στάδιο
- Βαθμός κυτταρικής διαφοροποίησης
- Μοριακοί δείκτες
- Ανοσοϊστοχημική έκφραση
- Right colorectal tumours
- Left colorectal tumours
- Stages
- Grade of differentiation
- Molecular markers
- Immunohistochemical expression
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Medical and Health Sciences
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/23596